Abstract
Lymphatic filariasis (LF) is a neglected tropical disease with severe consequences of functional disability and deformity in affected patients. The severity of the manifestations increases with age, and chronic lesions such as elephantiasis may become irreversible, causing disability and exposing affected individuals to social prejudice. LF can cause glomerular lesions, with one of the characteristics being the deposition of immune complexes, but also showing tubulointerstitial involvement. LF can have different clinical forms, from absence of symptoms to acute and chronic manifestations. The acute manifestations of LF, especially those caused by W. bancrofti, a species of interest in Brazil, are characterized by episodes of adenolymphangitis associated with fever and malaise. In men, this adenolymphangitis can be located in the genitals, presenting as acute orchiepididymitis. The chronic manifestations are especially important due to the limiting and stigmatizing patient characteristics. The clinical presentation depends on the location of the lymphatic damage. The best known is the lymphedema, which initially shows to be soft and progresses to hard and extensive edema, especially of the lower limbs. The diagnosis is based on specific findings described below and may be aided by nonspecific laboratory findings, such as eosinophilia, increased serum IgE levels, microscopic hematuria, and proteinuria. Treatment of LF is indicated for all individuals with active infection, regardless of whether or not they have clinical manifestations associated with the presence of the parasite.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Global programme to eliminate lymphatic filariasis: progress report, 2016. Wkly Epidemiol Rec. 2017;92:594.
Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância Epidemiológica. Guia de vigilância epidemiológica e eliminação da filariose linfática/ Ministério da Saúde, Secretaria de Vigilância em Saúde, Departamento de Vigilância Epidemiológica.- Brasília: Ministério da Saúde; 2009. 80p.: il. – (Séries A. Normas e Manuais Técnicos).
Neglected infectious diseases in the Americas: Success stories and innovation to reach the neediest. Washington, DC: PAHO; 2016.
Klion MD. Lymphatic filariasis: epidemiology, clinical manifestations and diagnosis. In: Post TW, editor. UpToDate. Waltham: UpToDate Inc. http://www.uptodate.com. Accessed on 23 Mar 2018.
Van Velthuysen ML, Florquin S. Glomerulopathy associated with parasitic infections. Clin Microbiol Rev. 2000;13(1):55–66.
Langhammer J, Birk HW, Zahner H. Renal disease in lymphatic filariasis: evidence for tubular and glomerular disorders at various stages of the infection. Tropical Med Int Health. 1997;2(9):875–84.
Pinheiro ME. Avaliação renal de pacientes com filariose bancroftiana. Tese (Doutorado em Medicina, pós graduação em Nefrologia). São Paulo: UNIFESP; 1998. p. 122.
World Health Organization. Lymphatic Filariais. http://www.who.int/lymphatic_filariasis/epidemiology/en/. Accessed in March 2018.
Orhiel TC. Filariae. In: Beaver PC, Jung RC, editors. Animals agents and vectors of human disease. 5th ed. Philadelphia: Lea & Febriger; 1985. p. 171–91.
Fontes G. Aspectos epidemiológicos da filariose linfática causada pela Wuchereria bancrofti no Estado de Alagoas. Tese (Doutorado em Ciências): UFMG; 1996. p. 179.
Rachou RG. Conceito e programa de profilaxia da filariose bancroftiana no Brasil. Rev Bras Malanolo Doenças Trop. 1960;12(1):11–40.
MS (Ministério da Saúde). O controle das endemias no Brasil (de 1979 a 1984). Brasília (DF): Superintendência de Campanhas de Saúde Pública, SUCAM; 1985; 154p.
Witt C, Ottesen EA. Lymphatic filariasis: an infection of childhood. Trop Med Int Health. 2001;6:582.
White GB. Studies on transmission of Bancroftian Filiariasis in North-Eastern Tanzania. Trans R Soc Trop Med Hyg. 1971;65:871–29.
Dreyer G, Coutinho A, Albuquerque R. Manifestações clínicas de filariose bancroftiana. Rev Assoc Med Bras. 1989;35:189–96.
Lymphatic filariasis: diagnosis and pathogenesis. WHO expert committee on filariasis. Bull World Health Organ. 1993, 71:3518.
Nutman TB, Kazura J. Lymphatic filariasis. In: Guerrant R, Walker DH, Weller PF, editors. Tropical infectious diseases : principles, pathogens and practice. 3rd ed. Philadelphia: Sauders Elsevier; 2011. p. 729. 20.
Dreyer G, Dreyer P, Norões J. Filariose Bancroftiana. In: Lucena VG, editor. Serviço de Clínica Médica do Hospital das Clínicas da UFPE, Rio de Janeiro, Guanabara Koogan: Condutas em Clínica Médica: Editora Universitária; 2007. p. 641–8.
World Health Organization Lymphatic filariasis: the disease and its control. Expert committee on filariasis. Fifth report. Technical reports series, 821; 1992; 75pp.
Weil GJ. Antigenemia in lymphatic filariasis. ExpParasitol. 1990;71:353–6.
Kibukamusoke JW. Chyluria. In: Tropical nephrology. Austrália: Citforge PTY. LTD; 1984. p. 360–8.
Kumar B, Karki S, Yadava SK. Role of fine needle aspiration cytology in diagnosis of filarial infestation. Diagn Cythopatol. 2011;39:8.
Dissanayake S, Rocha A, Noroes J. Evaluation of PCR-based methods for the diagnosis of infection in bancroftian filariasis. Trans R Soc Trop Med Hyg. 2000;94:526.
Guideline: alternative mass drug administration regimens to eliminate lymphatic filariasis. Geneva: World Health Organization; 2017.
Guideline: Treinamento em monitoramento e avaliação epidemiológica da intervenção com tratamentos coletivos para eliminação da filariose linfática: guia do participante. Itália: Organização Mundial de Saúde; 2015 .
Ndeffo-Mbah ML, Galvani AP. Global elimination of lymphatic filariasis. Published on line 21 dec 2016 https://doi.org/10.1016/S1473-3099(16)330544-8.
Irvine MA, Stolk WA, Smith ME, et al. Effectiveness of a triple-drug regimen for global elimination of lymphatic filariasis: a modelling study. Lancet Infect Disease 2016. Published on line 21 dec 2016 https://doi.org/10.1016/S1473-3099(16)30467-4.
Guideline: alternative mass drug administration regimens to eliminate lymphatic filariasis. Geneva: World Health Organization; 2017.
Rocha A, Santos EM, Oliveira P, Brandão E. Histórico das ações de controle da filariose linfática em Olinda, Pernambuco, Brasil. Rev Patol Trop. 2016;45:339–48.
Franco-Paredes C, Hidron A, Steinberg J. A woman from British Guyana with recurrent back pain and fever. Chyluria associated with infection due to Wuchereria bancrofti. Clin Infect Dis. 2006;42:1297–340.
Dufour B, Lepage T. Une cause rare d’hématurie: la filariose. J Urol Nephrol. 1978;84:231–5.
Mukherjee SK, Mukherjee AK, Sem JK. Filariasis with recurrent hematuria. JAMA. 1974;230(9):1254–5.
Nigam P, Sriwastava RP, Gupta SRS, Vajpayee GN. Haematuria in filariasis. Indian Med Assoc. 1979;62:249.
Sapico FL, Baltazar RF. Filariasis presenting as a case of gross hematuria. Acta Med Phil. 1967;3(4):273–5.
Bariety J, Barbier M, Laigre MC, Tcherma G, Samareq P, Milliez P. Protéinurie et loase. Estude histologique, optique et életronique d’un cas. Bull Soc Med Hop. Paris. 1967;118:1015–25.
Pillay VKG, Kirch E, Kurtzman NA. Glomerulopathy associated with filarial loiasis. J Am Med. Assoc. 1973;225:179.
Date A, Gunasekaran V, Kirubakaran MG, Shastry JCM. Acute eosinophilic glomerulonephritis with Bancroftian filariasis. Postg Med J. 1979;55:905–7.
Waugh DA, Alexander JH, Ibels LS. Filarial chyluria associated glomerulonephritis and therapeutic considerations in the chyluric patient. Aust N J Med. 1980;10:559–62.
Chugh KS, Singhai PC, Tewuri SC, Nath IVS, Datta EN. Acute glomerulonephritis associated with filariasis. Am J Trop Med Hyg. 1978;27(3):630–1.
Ormerod AD, Petersen J, Hussey JK, Weir J, Edward N. Immune complex glomerulonephritis and chronic anaerobic urinary infection-complications of filariasis. Postg Med J. 1983;59:730–3.
Yap HK, Woo KT, Yeo PPB, Chiang GSC, Singh M, Lim CH. The nephrotic syndrome associated with filariasis. Ann Acad Med. 1982;11(1):61–3.
Date A, Neela P, Shastry JCM. Membranoproliferative glomerulonephritis in a tropical environment. Ann Trop Med Parasitol. 1983;77(3):279–85.
Zuidema PJ. Renal changes in loiasis. Folia Med Neerl. 1971;14:168–72.
Dreyer G, Ottesen EA, Galdino E, Andrade L, Rocha A, Medeiros Z, Moura I, Casimiro I, Béliz F, Coutinho A. Renal abnormalities in microfilaraemic patients with Bancroftian Filariasis. Am J Trop Med Hyg. 1992;46(6):745–51.
Date A, Neela P, Shastry JCM. Membranoproliferative glomerulonephritis in a tropical environment. Ann Trop Med Parasitol. 1983;77(3):279–85.
Dissanayake S, Galahitiyawa SC, Ismail MM. Immune complexes in Wuchereria bancrofti infection in man. Bull World Health Organ. 1982;60(6):919–27.
Ganajana A, Bheema RAO US, Manonmani LM. Preliminary study on circulating immune complexes in Bancroftian filariasis. Indian J Med Res. 1982;76:146–50.
Kaliaraj P, Harinath BC, Ghirnikar SN. Detection of antigens and antibodies in filarial sera by counter current immuno electrophoresis. Curr Sci. 1977;46:603.
Lunde MN, Paranjape R, Lawley TJ, Ottesen EA. Filarial antigen in circulating immune complexes from patients with Wuchereria bancrofti filariasis. Am J Trop Med Hyg. 1988;38(2):366–71.
Ramaprasad P, Prasad GBKS, Harinath BC. Microfilaraemia, filarial antibody, antigen and immune complex levels in human filariasis before, during and after DEC therapy. Acta Trop. 1988;45:245–55.
Ngu JL, Chatelanat F, Leke R, Ndumbe P, Youmbissi J. Nephropathy in Cameroon: evidence for filarial derived immune-complex pathogenesis in some cases. Clin Nephrol. 1985;24(3):128–34.
Klei TR, Crowell WA, Thompson PE. Ultrastructural glomerular changes associated with filariasis. Am J Trop Med Hyg. 1974;38(4):608–18.
Norões J, Dreyer G, Santos A, Mendes VG, Medeiros Z, Addis D. Assessment of the efficacy of diethylcarbamazine on adult Wuchereria bancrofti in vivo. Trans Roy Soc Trop Med Hyg. 1997;91(1):78–81.
Langhammer J, Birb HW, Zahner H. Renal disease in lymphatic filariasis: evidence for tubular and glomerular disorders at various stages of the infection. Tropical Med Int Health. 1997;2(9):875–84.
Remuzzi G, Bertani T. Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules ? Kidney Int. 1990;38(3):384–94.
Olson JL, Hostetter TH, Rennke HG, Brenner BM, Venkatachalam MA. Altered glomerular permselectivity and progressive sclerosis following extreme ablation of renal mass. Kidney Int. 1982;22(2):112–26.
Schwartz MM, Bidani AK, Lewis EJ. Glomerular epithelial cell function and pathology following extreme ablation of renal mass. Am J Pathol. 1987;126(2):315–24.
Pereira AB. Estudo laboratorial das proteinúrias. J Bras Nefrol. 1992;14(1):7–11.
Waller KV, Ward KM, Mahan JD, Wismatt DK. Current concepts in proteinuria. Clin Chem. 1989;35(5):755–65.
Acknowledgments
To Professor Dra. Eliana Maria Mauricio da Rocha, current Full Professor at Universidade Federal de São João Del Rei – UFSJ, who was responsible, together with Professor Dr. Gilberto Fontes, for the study of LF in Maceió.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Pinheiro, M.E., Duarte, D.B., Oliveira, M.J.C., Fontes, G. (2020). Nephropathy in Lymphatic Filariasis. In: Bezerra da Silva Junior, G., De Francesco Daher, E., Barros, E. (eds) Tropical Nephrology. Springer, Cham. https://doi.org/10.1007/978-3-030-44500-3_11
Download citation
DOI: https://doi.org/10.1007/978-3-030-44500-3_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-44499-0
Online ISBN: 978-3-030-44500-3
eBook Packages: MedicineMedicine (R0)